At Novocure, every role contributes to extending the lives of people living with cancer. As our new HEOR (Health Economics and Outcomes Research) Manager, Spain, you’ll play a key part in this mission.
Based in Madrid the HEOR Manager will lead the development and execution of health economics and outcomes research activities that support market access, pricing, reimbursement, and HTA strategies across Novocure’s oncology portfolio in Spain.
This is a highly visible and technical role for a market access professional who combines strong health economics expertise with strategic thinking and stakeholder engagement skills. You will be responsible for translating clinical and economic evidence into compelling value propositions, adapting global economic models to local requirements, supporting reimbursement submissions, and serving as a trusted technical partner for both internal and external stakeholders. Working cross-functionally with Medical Affairs, Commercial, Global Value & Access, Finance, and external agencies, you will help shape access strategies that maximize patient access and support business growth.
Minimum Requirement
These additional qualifications are preferred:
We offer a flexible, trust-based hybrid working model for most of our office-based roles. Employees are asked to be in the office an average of three days per week, with the flexibility to choose which days’ work best for them. We understand that life is not always predictable, so if you need to adjust your schedule, such as leaving early or starting late occasionally, we trust you to balance your time in a way that works for both you and Novocure.
Novocure is a company with a powerful mission, to extend the lives of people living with some of the most aggressive forms of cancer. Here your work will have a direct impact on patients and those who care about them. Join a team of passionate, collaborative people who support each other, challenge one another, and innovate together. Here, you will connect, grow, and make a real difference. We are a company with the drive of a startup and the strength that comes with 25 years of success.
Novocure operates at a rare crossroad, where advanced medical technology converges with cutting-edge biotechnology. We are the only company to develop and commercialize Tumor Treating Fields (TTFields), a proprietary, groundbreaking therapy designed to disrupt cancer cell division. With us you will find a unique combination of laboratory research work alongside engineering development of advanced technologies. This fusion of disciplines positions us as true pioneers in oncology innovation, leading a new frontier in the treatment of aggressive cancers.
Our patient-forward values
-innovation
-focus
-drive
-courage
-trust
-empathy
If you are excited about this role, please apply.

We are a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy, Tumor Treating Fields. Our commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. We have ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and gastric cancer.
Headquartered in Switzerland, Novocure has U.S. operations in Portsmouth, New Hampshire and Chesterbrook, Pennsylvania. Additionally, Novocure has offices in Canada, Germany, Japan, Poland and Israel.